Familial hypobetalipoproteinemia: a review
- PMID: 12639976
- DOI: 10.1194/jlr.R300002-JLR200
Familial hypobetalipoproteinemia: a review
Abstract
We review the genetics and pathophysiology of familial hypobetalipoproteinemia (FHBL), a mildly symptomatic genetically heterogeneous autosomal trait. The minority of human FHBL is caused by truncation-specifying mutations of the APOB gene on chromosome 2. In seven families, linkage to chromosome 2 is absent, linkage is instead to chromosome 3 (3p21). In others, linkage is absent to both APOB and to 3p21. Apolipoprotein B-100 (apoB-100) levels are approximately 25% of normal, instead of the 50% expected based on the presence of one normal allele due to reduced rates of production. The presence of the truncating mutation seems to have a "dominant recessive" effect on apoB-100 secretion. Concentrations of apoB truncations in plasma differ by truncation but average at approximately 10% of normal levels. Lipoproteins bearing truncated forms of apoB are cleared more rapidly than apoB-100 particles. In contrast with apoB-100 particles cleared primarily in liver via the LDL receptor, most apoB truncation particles are cleared in renal proximal tubular cells via megalin. Since apoB defects cause a dysfunctional VLDL-triglyceride transport system, livers accumulate fat. Hepatic synthesis of fatty acids is reduced in compensation. Informational lacunae remain about genes affecting fat accumulation in liver, and the modulation of liver fat in the presence apoB truncation defects.
Similar articles
-
Absence of fatty liver in familial hypobetalipoproteinemia linked to chromosome 3p21.Metabolism. 2005 May;54(5):682-8. doi: 10.1016/j.metabol.2004.12.013. Metabolism. 2005. PMID: 15877300
-
Familial hypobetalipoproteinemia: genetics and metabolism.Cell Mol Life Sci. 2005 Jun;62(12):1372-8. doi: 10.1007/s00018-005-4473-0. Cell Mol Life Sci. 2005. PMID: 15818469 Free PMC article. Review.
-
Replication of linkage of familial hypobetalipoproteinemia to chromosome 3p in six kindreds.J Lipid Res. 2002 Mar;43(3):407-15. J Lipid Res. 2002. PMID: 11893777
-
Decreased production rates of VLDL triglycerides and ApoB-100 in subjects heterozygous for familial hypobetalipoproteinemia.Arterioscler Thromb Vasc Biol. 1999 Nov;19(11):2714-21. doi: 10.1161/01.atv.19.11.2714. Arterioscler Thromb Vasc Biol. 1999. PMID: 10559016 Clinical Trial.
-
The hypobetalipoproteinemias.Annu Rev Nutr. 1995;15:23-34. doi: 10.1146/annurev.nu.15.070195.000323. Annu Rev Nutr. 1995. PMID: 8527219 Review.
Cited by
-
The first Japanese case with familial combined hypolipidemia without any complications caused by loss-of function variants in ANGPTL3: Case report.Heliyon. 2024 Apr 21;10(8):e29924. doi: 10.1016/j.heliyon.2024.e29924. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38699738 Free PMC article.
-
ApoB100 and Atherosclerosis: What's New in the 21st Century?Metabolites. 2024 Feb 12;14(2):123. doi: 10.3390/metabo14020123. Metabolites. 2024. PMID: 38393015 Free PMC article. Review.
-
APOB is a potential prognostic biomarker in hepatocellular carcinoma.Discov Oncol. 2024 Feb 3;15(1):28. doi: 10.1007/s12672-024-00877-6. Discov Oncol. 2024. PMID: 38310202 Free PMC article.
-
ANGPTL3 Deficiency and Risk of Hepatic Steatosis.Circulation. 2023 Nov 7;148(19):1479-1489. doi: 10.1161/CIRCULATIONAHA.123.065866. Epub 2023 Sep 15. Circulation. 2023. PMID: 37712257
-
Case report of familial hypobetalipoproteinemia: a novel APOB mutation and literature review.Ann Pediatr Endocrinol Metab. 2023 Dec;28(Suppl 1):S9-S11. doi: 10.6065/apem.2244180.090. Epub 2023 Feb 3. Ann Pediatr Endocrinol Metab. 2023. PMID: 36758975 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
